An email from a ME/CFS reader on Probiotics

This person did a microbiome analysis thru Biome Sight, tranfered the data to Microbiome Prescription where Dr. Artificial Intelligence did an analysis based on over 20 million facts. I have a set of questions about the selection of probiotics during the course of the microbiome treatment. My first week-and-a-half using the Dr. AI plan went […]

Microclots and Microbiome: Interaction

The recent news of microclots with Long COVID with researchers looking for the same issue with Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) caused me to do this summary of my understanding. Some literature: SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19 [2021] Prevalence of symptoms, comorbidities, fibrin amyloid microclots […]

Phospholipids, the Microbiome and ME/CFS

For almost a decade I have suspected that there was an interaction between the microbiome and Antiphospholipid syndrome (APS) also known as Hughes Syndrome (after the MD, see below). This is also called  “sticky blood syndrome” [HealthLine]. For some researchers, it is deemed to be a significant contributor to fatigue in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) [1999 D. Berg] […]

Brain Fog – Hypoperfusion of the brain in ME/CFS and Long Covid

A reader followed a new article that seems to bear strong echoes from research done 23 years ago by David Berg at Hemex Labs. The article is “CFS/ME, FM: THERAPEUTIC TEST AND FIRST TREATMENT SCHEME FOR PATIENTS WITH CHRONIC FATIGUE AND BRAIN FOG TO ASSIST THE DIAGNOSIS OF PERSISTENT CLOTS AND HYPOPERFUSION.” Oct 2021  Our […]

A review of a ME/CFS Microbiome

Every ME/CFS microbiome is different. IMHO, the root cause is a bad mixture of chemicals and chemical signals being produced by a dysfunctional microbiome that has reached a stabilization point. Patient This reader provided detail background which is always desired. Background: 35yr Male have had ME/CFS for about 7 years now since 2015. In 2018 […]